PRPH
Price
$2.08
Change
-$0.11 (-5.02%)
Updated
Nov 5, 04:00 PM (EDT)
2 days until earnings call
RXST
Price
$51.74
Change
+$0.49 (+0.96%)
Updated
Nov 5, 04:00 PM (EDT)
2 days until earnings call
Ad is loading...

PRPH vs RXST

Header iconPRPH vs RXST Comparison
Open Charts PRPH vs RXSTBanner chart's image
ProPhase Labs
Price$2.08
Change-$0.11 (-5.02%)
Volume$8.08K
CapitalizationN/A
RxSight
Price$51.74
Change+$0.49 (+0.96%)
Volume$126.09K
CapitalizationN/A
View a ticker or compare two or three
PRPH vs RXST Comparison Chart
Loading...
PRPH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RXST
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
PRPH vs. RXST commentary
Nov 06, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRPH is a Hold and RXST is a StrongSell.

COMPARISON
Comparison
Nov 06, 2024
Stock price -- (PRPH: $2.19 vs. RXST: $51.25)
Brand notoriety: PRPH and RXST are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: PRPH: 146% vs. RXST: 144%
Market capitalization -- PRPH: $116.75M vs. RXST: $1.91B
PRPH [@Medical Specialties] is valued at $116.75M. RXST’s [@Medical Specialties] market capitalization is $1.91B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.97B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRPH’s FA Score shows that 1 FA rating(s) are green whileRXST’s FA Score has 0 green FA rating(s).

  • PRPH’s FA Score: 1 green, 4 red.
  • RXST’s FA Score: 0 green, 5 red.
According to our system of comparison, RXST is a better buy in the long-term than PRPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRPH’s TA Score shows that 4 TA indicator(s) are bullish while RXST’s TA Score has 4 bullish TA indicator(s).

  • PRPH’s TA Score: 4 bullish, 3 bearish.
  • RXST’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PRPH is a better buy in the short-term than RXST.

Price Growth

PRPH (@Medical Specialties) experienced а -8.75% price change this week, while RXST (@Medical Specialties) price change was +1.99% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.55%. For the same industry, the average monthly price growth was -0.26%, and the average quarterly price growth was -1.49%.

Reported Earning Dates

PRPH is expected to report earnings on Mar 26, 2025.

RXST is expected to report earnings on Mar 11, 2025.

Industries' Descriptions

@Medical Specialties (+0.55% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXST($1.91B) has a higher market cap than PRPH($117M). PRPH has higher P/E ratio than RXST: PRPH (17.01) vs RXST (15.27). RXST YTD gains are higher at: 27.108 vs. PRPH (-51.549). PRPH has higher annual earnings (EBITDA): -9.64M vs. RXST (-41.04M). RXST has more cash in the bank: 127M vs. PRPH (3.27M). RXST has less debt than PRPH: RXST (3.01M) vs PRPH (18.9M). RXST has higher revenues than PRPH: RXST (89.1M) vs PRPH (62.7M).
PRPHRXSTPRPH / RXST
Capitalization117M1.91B6%
EBITDA-9.64M-41.04M23%
Gain YTD-51.54927.108-190%
P/E Ratio17.0115.27111%
Revenue62.7M89.1M70%
Total Cash3.27M127M3%
Total Debt18.9M3.01M627%
FUNDAMENTALS RATINGS
PRPH: Fundamental Ratings
PRPH
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
91
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
19
SEASONALITY SCORE
1..100
45

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PRPHRXST
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 6 days ago
82%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 22 days ago
80%
Bearish Trend 6 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
72%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
PRPH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RXST
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AWPAX19.950.03
+0.15%
AB Sustainable Intl Thematic A
TCIEX23.480.03
+0.13%
Nuveen International Eq Idx R6
ESISX14.950.02
+0.13%
Parametric International Equity R6
VRSGX36.46N/A
N/A
Virtus KAR Small-Cap Growth R6
HMSIX12.35N/A
N/A
Hennessy Midstream Institutional

PRPH and

Correlation & Price change

A.I.dvisor tells us that PRPH and ANIP have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRPH and ANIP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRPH
1D Price
Change %
PRPH100%
+2.34%
ANIP - PRPH
28%
Poorly correlated
-3.73%
RXST - PRPH
23%
Poorly correlated
+0.29%
LFCR - PRPH
21%
Poorly correlated
+1.79%
ATRC - PRPH
21%
Poorly correlated
+0.46%
ASRT - PRPH
21%
Poorly correlated
+2.91%
More

RXST and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXST has been loosely correlated with AXNX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if RXST jumps, then AXNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXST
1D Price
Change %
RXST100%
+0.29%
AXNX - RXST
43%
Loosely correlated
+0.01%
RDNT - RXST
41%
Loosely correlated
+2.18%
OFIX - RXST
38%
Loosely correlated
+2.06%
CSTL - RXST
38%
Loosely correlated
+1.48%
ALGN - RXST
37%
Loosely correlated
+1.06%
More